• Life At Cipla

    Cipla Foundation Brings Together Cipla Bengaluru’s First Marathon Team

    Teams that run together, stay together! This year, Cipla Marathoners from Bengaluru came together to support Cipla Foundation’s purpose of Caring for life at the TCS World 10K Marathon 2018. This year in January, the Foundation for the first time brought together Dream Run team at the Tata Mumbai Mumbai Marathon 2018 which officially carried the […]

    June 20, 2018
  • In The News

    Cipla Receives Final Approval for Generic Sustiva® (Efavirenz Tablets 600mg)

    Press Release Cipla Limited, today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Efavirenz Tablets 600mg from the United States Food and Drug Administration (US FDA). Cipla’s Efavirenz Tablets 600mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s, Sustiva®. It is indicated in combination with […]

  • Leaders Speak

    Campus To Corporate

    This is the time of the year when graduates from technical and business schools join organizations across India. Often referred to as Graduate Engineering Trainees, Management Trainees, Post Graduate Trainees etc., this is a key transition that these youngsters are going through in their lives. While they are taking a plunge into the world of […]

  • Life At Cipla

    International Archives Day: How To Preserve Your Memories, Experiences And More

    Demystifying archiving and preserving old photographs, books and documents.

  • In The News

    Cipla Receives Final Approval for Generic Isuprel® (Isoproterenol Hydrochloride Injection USP, 0.2mg/mL)

    Press Release Cipla Limited (“Cipla”), today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (US FDA). Cipla’s Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is AP-rated generic therapeutic equivalent version of Hospira Inc’s […]